Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial.
Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate.
Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers.
Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000.
Recombinant FVIIa in the treatment of warfarin bleeding.
Prescribing Info - Questions - Drug Info - Links - PDA Software - Article Summaries - Slideshows - Review Articles - What's New
 
© Copyright 1999-2017 DocMD.com. All Rights Reserved.